Using Bidens And Achillea To Treat Acute Finger Bowel Ulcers and Researching Its Phenolic Characteristics
DOI:
https://doi.org/10.37547/ajbspi/Volume05Issue04-07Keywords:
Gastrointestinal disorders, Helicobacter pylori infectionsAbstract
One of the most prevalent gastrointestinal disorders is duodenal ulcers. Approximately 5–10% of people worldwide will at some point in their lives suffer with this illness. There are two to three times as many males as females. Between the ages of 30 and 50, more develops. Disease rates are high in industrialized nations like Uzbekistan, the US, and Europe. Although the illness is very uncommon in Asia and Africa, Helicobacter pylori infections are quite common in places with inadequate sanitation. Ninety-five percent of cases are caused by Helicobacter pylori infection. Fast food that is hot, salty, and greasy causes malnutrition. Nervousness and psychological aspects. Bidens and Achillea are used to treat duodenal ulcers. When it comes to gastrointestinal disorders, the herbs Bidens and Achillea are said to be quite beneficial. They have antibacterial, anti-inflammatory, and wound-finishing properties. A solution containing 14.286 mg/L of each vitamin was created after the first 200 µL of B1, B6, B3, B12, and PP were removed. This led to the creation of standard solutions with 7.143, 3.571, and 1.786 mg/l. Standard vitamin C solutions with concentrations of 286, 143, 71.5, and 57.2 mg/l were also prepared. Pure water with a concentration of 0 mg/l was used to construct a calibration graph.
References
Askarov, I. R., Abdullayev, S. S. son, Mamatqulova, S. A., Abdullayev, O. S., & Abdulloyev, S. X. (2024). DEVELOPMENT OF A METHODOLOGY FOR DETERMINING THE AMOUNT OF WATER-SOLUBLE VITAMINS IN THE YUSSCH METHOD (ON THE EXAMPLE OF CHILONJIYDA). Fergana State University, 30 (5), 61. Retrieved from https://journal.fdu.uz/index.php/sjfsu/article/view/4679
Askarov,I. R., Phytotherapy. Tashkent. "The art and technology of publishing is the printing press." In 2023.
Ahmed I., Kassem W., Salam Y. et al. Outcome of Cytomegalovirus Colitis in Inflammatory Bowel Dis- ease with Different Regimes of Ganciclovir. Middle East J Dig Dis. 2018;10(4):220–229. doi: 10.15171/ mejdd.2018.114.
Axelrad J.E., Joelson A., Green P.H.R. et al. Enteric Infections Are Common in Patients with Flares of Inflammatory Bowel Disease. Am J Gastroenterol. 2018;113(10):1530–1539. doi: 10.1038/ s41395-018-0211-8.
Annese V., Daperno M., Rutter M.D. et al. European evidence based consensus for endoscopy in in- flammatory bowel disease. J Crohns Colitis. 2013;7(12):982–1018. doi: 10.1016/j.crohns.2013.09.016.
Annese V., Beaugerie L., Egan L. et al. European Evidence-based Consensus: Inflammatory Bowel Disease and Malignancies. J Crohns Colitis. 2015;9(11):945–965. doi: 10.1093/ecco-jcc/jjv141.
Bansal J., Jenaw R.K., Rao J. et al. Effectiveness of plain radiography in diagnosing hollow viscus perforation: study of 1,723 patients of perforation peritonitis. Emerg Radiol. 2012;19(2):115–119. doi: 10.1007/s10140-011-1007-y.
Budesonide enema in distal ulcerative colitis. A randomized dose-response trial with predni- solone enema as positive control. The Danish Budesonide Study Group. Scand J Gastroenterol. 1991;26(12):1225–1230. doi: 10.3109/00365529108998618.
Brunner M., Assandri R., Kletter K. et al. Gastrointestinal transit and 5-ASA release from a new mesalazine extended-release formulation. Aliment Pharmacol Ther. 2003;17(3):395–402. doi: 10.1046/j.1365-2036.2003.01445.x.
Magro F., Gionchetti P., Eliakim R. et al. Third European Evidence-based Consensus on Diagno- sis and Management of Ulcerative Colitis. Part 1: Definitions, Diagnosis, Extra-intestinal Manifes- tations, Pregnancy, Cancer Surveillance, Surgery, and Ileo-anal Pouch Disorders. J Crohns Colitis. 2017;11(6):649–670. doi: 10.1093/ecco-jcc/jjx008.
Travis S.P., Dinesen L. Remission in trials of ulcerative colitis: what does it mean? Pract Gastroen- terol. 2010;30:17–20.
Molodecky N.A., Soon I.S., Rabi D.M. et al. Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review. Gastroenterology. 2012;142(1):46.e42–54. e42. doi: 10.1053/j.gastro.2011.10.001.
Ng S.C., Shi H.Y., Hamidi N. et al. Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies. Lancet. 2017;390(10114):2769– 2778. doi: 10.1016/S0140-6736(17)32448-0.
Mak W.Y., Zhao M., Ng S.C., Burisch J. The epidemiology of inflammatory bowel disease: East meets west. J Gastroenterol Hepatol. 2020;35(3):380–389. doi: 10.1111/jgh.14872.
Shivananda S., Lennard-Jones J., Logan R. et al. Incidence of inflammatory bowel disease across Europe: is there a difference between north and south? Results of the European Collaborative Study on Inflammatory Bowel Disease (EC-IBD). Gut. 1996;39(5):690–697. doi: 10.1136/gut.39.5.690.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Ibragim Askarov, Khabibullo Kodirov
This work is licensed under a Creative Commons Attribution 4.0 International License.
